Liraglutide obesity drug molecule

Liraglutide obesity drug molecule


Rights Managed


Liraglutide. Molecular model of the drug Liraglutide, used to treat obesity and diabetes. This is a long-acting glucagon-like peptide-1 receptor agonist which binds to the same receptors as does the body's GLP-1 hormone. It stimulates insulin secretion which controls blood sugar levels, decreases the production of the hormone glucagon, slows gastric emptying, and reduces appetite. It is used for the management of type 2 diabetes under the trade name Victoza, and as a treatment for obesity in adults under the name Saxenda.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}